Tempest Therapeutics. EMA Orphan Drug Designation (ODD) builds on U.S. Food & Drug Administration (FDA) ODD and Fast Track Designation, underscoring the urgent need for new treatment options ...

The president has handed out a flurry of pardons in recent weeks. By Katherine Faulders, Rachel Scott, and Hannah Demissie. May 29, 2025, 3:32 PM. 2:58.

A light flurry of snow chilled the crowd as author Terry Tempest Williams, Utah Senate Minority Leader Luz Escamilla, Regina Lopez-Whiteskunk of the Ute Mountain Ute Tribe and Latiné university ...

I go into more detail in our Tempest Rising review, but in summary, while Slipgate's RTS game borrows from the mood and overtones of Command and Conquer, it's much more than just a tribute act ...

Accompanying the Tempest and Gemini into the world is a series of new fittings for the rest of the range, including various packs aptly called Beach Days, Road Trips, and Snow Days, but also new ...

Our Tempest Rising review breaks down what makes this sci-fi real-time strategy game interesting, in spite of its overly familiar structure. New to Shacknews? Signup for a Free Account.

Note: This review specifically covers the multiplayer mode of Tempest Rising. For thoughts on the story mode, check out the Tempest Rising single-player campaign review. The problem with Tempest ...

Tempest plans to complete the significant reduction in its head count by April 30. The biotech expects the action to cost it about $1.5 million, mainly in the form of severance payments.

Tempest Rising, a real-time strategy game that's being called a "spiritual successor" and an homage to Command & Conquer, is now available to everyone.It was supposed to be released on April 24 ...

Taken at face value, Tempest Rising could pass for a new Command and Conquer game, but while it stands on the shoulders of Westwood's greatest works, its mechanical subtleties, ...

Tempest Rising’s two good-sized single-player campaigns are a large helping of comfort food for RTS fans old enough to remember Command & Conquer in its heyday, and a way for everyone else to ...

HC Wainwright reaffirmed their neutral rating on shares of Tempest Therapeutics (NASDAQ:TPST – Free Report) in a report published on Thursday morning, Marketbeat reports. They currently have a ...